DL
Therapeutic Areas
PersonGen BioTherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TAA06 injection | T-cell malignancies (specific type not specified) | Phase 1 |
| LV009 injection | Relapsed/Refractory CD19-positive hematologic malignancies | Clinical Trial (phase not specified) |
| CD7-CAR-T program | T-cell malignancies | Not specified |